Compare UVE & INMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | UVE | INMD |
|---|---|---|
| Founded | 1990 | 2008 |
| Country | United States | Israel |
| Employees | N/A | N/A |
| Industry | Property-Casualty Insurers | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 957.6M | 842.0M |
| IPO Year | 1996 | 2018 |
| Metric | UVE | INMD |
|---|---|---|
| Price | $39.49 | $13.97 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 1 | 5 |
| Target Price | ★ $40.00 | $17.33 |
| AVG Volume (30 Days) | 192.1K | ★ 653.9K |
| Earning Date | 04-23-2026 | 05-06-2026 |
| Dividend Yield | ★ 1.97% | N/A |
| EPS Growth | ★ 214.43 | N/A |
| EPS | ★ 1.88 | N/A |
| Revenue | ★ $1,603,915,000.00 | N/A |
| Revenue This Year | N/A | $1.74 |
| Revenue Next Year | $2.88 | $3.26 |
| P/E Ratio | $21.58 | ★ $10.11 |
| Revenue Growth | ★ 5.48 | N/A |
| 52 Week Low | $21.96 | $12.72 |
| 52 Week High | $41.96 | $16.74 |
| Indicator | UVE | INMD |
|---|---|---|
| Relative Strength Index (RSI) | 59.81 | 47.19 |
| Support Level | $29.57 | $13.32 |
| Resistance Level | $41.96 | $14.70 |
| Average True Range (ATR) | 1.62 | 0.30 |
| MACD | 0.13 | -0.07 |
| Stochastic Oscillator | 71.09 | 47.95 |
Universal Insurance Holdings Inc is an insurance holding company. Through its subsidiaries, the company mainly offers property and casualty insurance and value-added insurance services. It develops, markets, and underwrites insurance products for consumers predominantly in the personal residential homeowners lines of business and performs all other insurance-related services for its primary insurance entities, including risk management, claims management, and distribution. The group offers the following types of personal residential insurance: homeowners, renters/tenants, condo unit owners, and dwelling/fire, through an independent agent network and online distribution channels across multiple states in the United States of America.
InMode Ltd provides minimally and non-invasive surgical aesthetic and medical treatment solutions. Its products and solutions address three energy-based treatment categories that include face & body contouring, medical aesthetics, and women's health. InMode has developed products using its technology for plastic surgery, dermatology, gynecology, and ophthalmology. Its product platforms include BodyTite, Optimas, Votiva, Contoura, Triton, EmbraceRF, EvolveX, Evoke, EmpowerRF, and Morpheus8, among others. Geographically, the company generates the majority of its revenue from the United States, followed by Europe, Asia, Israel, and other regions.